DaVita Inc. is set to announce its latest quarterly earnings on Monday, May 4th. Analysts estimate an earnings per share of $2.33.
DaVita Inc. (DVA) is currently priced at $151.26, showing a price increase of $1.21 (0.806%) from the previous close. Trading volume stands at $84,246, 8.3% above the average.
In the latest earnings report on Tuesday, October 28th, DaVita Inc. reported an earnings per share of $2.51, below the consensus estimate of $3.17.
DaVita Inc.'s cash flow activities indicate a net change in cash of -$37.67 million, with operating cash flow at $540.73 million and capital expenditure of -$145.43 million.
The income statement reveals a gross profit of $1 billion, operating income of $551.21 million, and a net income of $234.22 million, translating to an earnings per share of $2.51.
Key ratios for DaVita Inc. include a net profit margin of 6.47%, return on assets at 1.34%, and a price-to-earnings ratio of 10.44.
DaVita Inc.'s balance sheet displays total assets of $17.48 billion, total liabilities of $16.32 billion, and net debt of $14.29 billion.
This real-time financial report provides insights into DaVita Inc.'s performance and financial health leading up to the upcoming earnings announcement.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.